ORTIN LABORATORIES Share Price

ORTIN LABORATORIES Share Price

NSE: ORTINGLOBE
|
Pharmaceuticals
|
S Cap
₹ 15.15
-₹0.28 (-1.81%)
1D
Last updated 03 Sep, 2026, 10:47 IST

ORTIN LABORATORIES Share Price Today

As of 3 Sep 2026, ORTIN LABORATORIES share price is ₹15.15. The stock opened at ₹15.05, compared to its previous close of ₹15.43. During today's trading session, ORTIN LABORATORIES share price moved in the range of ₹15.05 to ₹15.15, with an average price of ₹15.10 for the day. Looking at its last 52-week, the stock has touched a low of ₹10.66 and a high of ₹21.30. On the performance front, ORTIN LABORATORIES share price has declined by 5.74% over the last six months and is up 19.52% on a year-on-year basis.

₹15.05
1.81% down today
₹15.15
1D LOW
1D HIGH

ORTIN LABORATORIES Returns Calculator

Circuit
L
H
₹14.66
₹16.20
52-week
L
H
₹10.66
₹21.30

About ORTIN LABORATORIES

ORTIN LABORATORIES Share Price
ISIN
INE749B01020
Sector Market Cap
₹ 12.55 Cr

Ortin Global Limited is an India-based company, which is engaged in the manufacturing and trading of pharmaceuticals, drugs and intermediates, to manufacture, sell or export all types of medicines, including ayurvedic, homeopathic, Unani, biochemical, nature cure and others. The Company is also engaged in the real estate business.

ORTIN LABORATORIES Financial Highlights

  • Revenue: ORTIN LABORATORIES reported revenue of ₹0.42 crore in FY26 vs ₹0.38 crore in FY25. It showed an increase of 10.53% on a yearly basis.
  • Operating Profit: ORTIN LABORATORIES reported an operating loss of ₹0.72 crore in FY26 vs ₹0.84 crore in FY25. It showed an increase of 14.29% on a year-on-year basis.
  • Net Profit: ORTIN LABORATORIES reported a net loss of ₹0.74 crore in FY26 vs ₹0.85 crore in FY25. It showed an increase of 12.94% on a yearly basis.

ORTIN LABORATORIES Quarterly Result Highlights

  • ORTIN LABORATORIES reported revenue of ₹15.96 crore in Jun 2012, compared with ₹19.96 crore in Mar 2012, representing a decrease of 20.04% on a quarter-on-quarter (QoQ) basis.
  • ORTIN LABORATORIES reported an operating profit of ₹0.66 crore in Jun 2012, compared with ₹2.18 crore in Mar 2012, representing an increase of 130.28% on a quarter-on-quarter (QoQ) basis.
  • ORTIN LABORATORIES reported a profit of ₹0.44 crore in Jun 2012, compared with ₹1.92 crore in Mar 2012, reflecting an increase of 122.92% on a QoQ basis.
Know more
Promoters
1.23%
FII
1.80%
Other DII
0.00%
Retail and other
96.96%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20251.68%
Dec 20251.68%
Mar 20261.68%
Jun 20261.80%
Mkt Cap Cr
12.55
P/E
-13.90
P/B
10.11
ROE
-59.85%
D/E
0.81
ROCE
-32.17%
Div. Yield
0.00%
EPS(TTM)
-0.91
Turnover
0.01
EV/EBITDA
-14.94
Net Margin
0.00%
Op. Margin
0.00%
ROA
-19.35%
Quick Ratio
0.00
Curr. Ratio
1.60
Based on fundamentals, this stock's
Step 4 of 5
Performance
Good
Ortin Global outperforming most market indices
Step 1 of 5
Valuation
Overvalued
Ortin Global appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Ortin Global earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,45,081.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,16,114.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,554.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,312.2017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma97,467.0047.546.0311.74%0.3413.13%397.020.04%0.4449.37
Aurobindo Pharma95,299.8025.682.529.25%0.1911.76%394.820.24%0.3841.58

ORTIN LABORATORIES Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2012
Revenue86.05
Operating profit2.61
Net profit1.28

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.34₹2.11₹6.02₹8.23
Other Income₹0.04₹0.17₹0.04₹0.19
Total Revenue₹0.38₹2.28₹6.06₹8.43
Total Expenses₹1.24₹9.36₹6.15₹8.96
Profit Before Tax-₹0.84-₹7.08-₹0.11-₹0.53
Tax₹0.01₹0.97-₹0.02-₹0.13
Profit After Tax-₹0.85-₹8.04-₹0.09-₹0.40
EPS - Basic-₹1.04-₹9.89-₹0.12-₹0.49
EPS - Diluted-₹1.04-₹9.89-₹0.12-₹0.49

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹0.84-₹7.08-₹0.11-₹0.53
Income before WC changes-₹0.82-₹4.22₹0.53₹0.57
Change in Assets₹0.90₹2.32-₹1.08₹0.81
Change in Liabilities-₹0.48-₹1.59₹0.30₹0.77
Change in WC₹0.41₹0.72-₹0.78₹1.58
Cash flow from Operations-₹0.41-₹4.79-₹0.25₹2.15
Cash flow from Investing₹0.00₹12.00₹0.01-₹0.13
Cash flow from Financing₹0.33-₹3.49₹0.90-₹0.47
Total Cash Flow-₹0.09₹3.72₹0.66₹1.55
Cash (Start of the year)₹0.46-₹3.26-₹3.92-₹5.47
Cash (End of the year)₹0.37₹0.46-₹3.26-₹3.92

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹0.44₹0.32₹14.66₹14.96
Current Assets₹3.34₹6.34₹6.54₹5.75
Total Assets₹3.78₹6.66₹21.20₹20.70
Current Liabilities₹1.55₹2.04₹6.98₹7.61
Net Current Asset₹1.79₹4.31-₹0.44-₹1.86
Non-Current Liabilities₹0.25₹1.80₹3.35₹2.14
Equity Capital₹1.98₹2.82₹10.86₹10.96
Total Equity & Liabilities₹3.78₹6.66₹21.20₹20.70
* All values are in INR Crore
Qty
Bid
1048
15.15
190
15.1
260
15.05
10
15
4000
14.95
Ask
Qty
15.77
100
15.78
140
15.8
106
15.98
500
15.99
5300
Bid Total: 5508
Ask Total: 6146
Buy orders: 47%
Sell orders: 53%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
49.52
Neutral
ATR (14)
0.86
Neutral
STOCH(9,6)
56.85
Neutral
STOCH RSI (14)
55.29
Neutral
ADX(9)
19.34
Bullish
UO(9)
53.95
Neutral
ROC(12)
-2.89
Bearish
WillR(14)
-56.32
Neutral
Period
Simple value
Exponential vaue
5D
15.32
15.43
10D
15.42
15.42
20D
15.44
15.43
50D
15.71
15.59
100D
15.75
15.59
Volume trend — traded volume by day
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug0L
Average0L
Compare against other stocks
ORTIN LABORATORIES Share Price
ORTIN LABORATORIES
Pharmaceuticals
Add Stock
Add Another

ORTIN LABORATORIES Share Price FAQs